Tearlab Corporation (TEAR) 0.59 $TEAR
TearLab Corporation to Present at the 6th Annual LD Micro Invitational
ACCESSWIRE - Thu Jun 02, 3:15PM CDT
SAN DIEGO, CA / ACCESSWIRE / June 2, 2016 / TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or the "Company"
, a company that develops and markets point of care ophthalmic in-vitro diagnostics, today announced that its Chief Executive Officer, Seph Jensen, will present a Company overview and business update at the 6th Annual LD Micro Invitational on Thursday, June 9, 2016 at 11:30 am PT/2:30 pm ET. The conference will be held at the Luxe Sunset Bel Air Hotel in Los Angeles, CA.
TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab Corporation Reports Q1-16 Financial Results
GlobeNewswire - Wed May 04, 3:02PM CDT
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or the "Company" today reported its consolidated financial results for the first quarter ended March 31, 2016. All dollar amounts are expressed in U.S. currency and results are reported in accordance with United States generally accepted accounting principles.
TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab Announces $17.3 Million Registered Public Offering
GlobeNewswire - Wed May 04, 6:00AM CDT
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or the "Company" announced today the pricing of a public offering of the Company's common stock, resulting in total gross proceeds of approximately $17.3 million. The offering is expected to close on or about May 9, 2016, subject to satisfaction of customary closing conditions.
TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab to Release First Quarter 2016 Financial Results on May 4, 2016 - Conference Call to Follow
GlobeNewswire - Mon Apr 25, 7:30AM CDT
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or the "Company" will announce its first quarter 2016 financial results after market close on Wednesday, May 4, 2016.
TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab Announces First Quarter 2016 Preliminary Financial Estimates
GlobeNewswire - Wed Apr 20, 4:20PM CDT
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or "the Company" announced today certain preliminarily unaudited financial estimates for the first quarter of 2016.
TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab to Participate in the 28th Annual ROTH Conference
GlobeNewswire - Thu Mar 10, 3:30PM CST
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or the "Company" today announced its Chief Financial Officer, Wes Brazell, will present an update on the Company's business at the 28th Annual ROTH Conference on Monday, March 14, 2016 at 3:30 p.m. Pacific Time. The conference will be held at the Ritz Carlton in Dana Point, CA.
TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab Reports Fourth Quarter and Full Year 2015 Financial Results
GlobeNewswire - Tue Mar 08, 3:03PM CST
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or the "Company" today reported its consolidated financial results for the fourth quarter and full year ended December 31, 2015. All dollar amounts are expressed in U.S. currency and results are reported in accordance with United States generally accepted accounting principles.
TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab Announces Withdrawal of Proposed Public Offering of Common Stock
GlobeNewswire - Tue Feb 09, 8:00PM CST
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or the "Company" announced today that it has withdrawn the proposed underwritten public offering of its common stock, due to market conditions.
TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab to launch USD15.0m common stock in underwritten public offering
M2 - Tue Feb 02, 6:09AM CST
Eye care technology company TearLab (Nasdaq CM:TEAR) disclosed on Monday that it proposes to issue USD15.0m shares of its common stock in an underwritten public offering.
TEAR: 0.59 (-0.01)
TearLab Announces Proposed Public Offering of Common Stock
GlobeNewswire - Mon Feb 01, 6:00AM CST
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or "the Company" announced today its intention to offer, subject to market and other conditions, shares of its common stock in an underwritten public offering. The Company currently estimates the size of the offering at $15.0 million. In addition, TearLab intends to grant the underwriters of the offering the right for a period of 30 days to purchase up to an additional $2.25 million of shares of common stock at the public offering price, less underwriting discounts and commissions. The proceeds of the offering will be used for general corporate purposes, including commercializing our products, research and product development, capital expenditures, and working capital.
TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab Announces Fourth Quarter 2015 Preliminary Financial Estimates and Provides Corporate Update
GlobeNewswire - Mon Feb 01, 6:00AM CST
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or "the Company" announced today certain preliminarily unaudited financial estimates for the fourth quarter of 2015 and provided an update on its business.
TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
BUYINS.NET: XPP, SIMO, SHM, ITM, AGZ, TEAR Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Dec 30, 6:15AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ProShares Ultra FTSE China 25 (NYSE:XPP), Silicon Motion Technology Corp (NASDAQ:SIMO), SPDR Nvn Barclys Cptl Shrt Trm Mncpl Bnd (NYSE:SHM), Intema Solutions Inc (NYSE:ITM), iShares Barclays Agency Bond Fund (NYSE:AGZ), Tearlab Corp (NASDAQ:TEAR) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
XPP: 44.04 (+1.75), TEAR: 0.59 (-0.01), ITM: 24.88 (+0.01), SHM: 49.05 (-0.01), AGZ: 115.79 (-0.25), SIMO: 52.20 (+1.81)
TearLab to Participate in November Investor Conferences
GlobeNewswire - Wed Nov 04, 8:00AM CST
TearLab Corporation (NASDAQ:TEAR); (TSX:TLB) ("TearLab" or the "Company" announced today that it will participate in two investor conferences in November.
TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab Corporation to Release Q3 2015 Financial Results on November 5, 2015
GlobeNewswire - Mon Oct 19, 3:53PM CDT
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or the "Company" expects to announce its Q3 2015 financial results after market close on Thursday, November 5, 2015. TearLab is pleased to invite all willing participants in a conference call during which time financial results will be discussed. This call will be held at 4:30pm Eastern at 877-303-1593.
TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
Medical Necessity of Tear Osmolarity Testing in the Diagnosis and Management of Dry Eye Disease Confirmed in Recently Published Medicare Local Coverage Determination
GlobeNewswire - Fri Oct 09, 6:00AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" announced today that First Coast Service Options, Inc. (the Medicare Area Contractor for Florida, Puerto Rico and the US Virgin Islands) has published a Local Coverage Determination (LCD) that confirms the role of tear osmolarity testing in the diagnosis and management of moderate to severe dry eye patients.
TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab to Participate in Craig-Hallum's 6th Annual Alpha Select Conference
GlobeNewswire - Thu Sep 10, 7:00AM CDT
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or the "Company" announced today that its Chief Executive Officer, Elias Vamvakas, will present an update on the Company's business at the 6th Annual Craig-Hallum Alpha Select Conference on Thursday, September 17, 2015 at 1:30 p.m. Eastern Time at the Convene Conference Center in New York City.
TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab Corporation to Release Q2 2015 Financial Results on August 6, 2015
GlobeNewswire - Mon Jul 20, 8:30AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" expects to announce its Q2 2015 financial results after market closes on Thursday, August 6, 2015. TearLab is pleased to invite all willing participants in a conference call during which time financial results will be discussed. This call will be held at 4:30pm Eastern at 877-303-1593.
TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab Corporation to Present at the 6th Annual LD Micro Invitational
ACCESSWIRE - Thu Jun 02, 3:15PM CDT
SAN DIEGO, CA / ACCESSWIRE / June 2, 2016 / TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or the "Company"
, a company that develops and markets point of care ophthalmic in-vitro diagnostics, today announced that its Chief Executive Officer, Seph Jensen, will present a Company overview and business update at the 6th Annual LD Micro Invitational on Thursday, June 9, 2016 at 11:30 am PT/2:30 pm ET. The conference will be held at the Luxe Sunset Bel Air Hotel in Los Angeles, CA. TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab Corporation Reports Q1-16 Financial Results
GlobeNewswire - Wed May 04, 3:02PM CDT
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or the "Company"
today reported its consolidated financial results for the first quarter ended March 31, 2016. All dollar amounts are expressed in U.S. currency and results are reported in accordance with United States generally accepted accounting principles. TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab Announces $17.3 Million Registered Public Offering
GlobeNewswire - Wed May 04, 6:00AM CDT
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or the "Company"
announced today the pricing of a public offering of the Company's common stock, resulting in total gross proceeds of approximately $17.3 million. The offering is expected to close on or about May 9, 2016, subject to satisfaction of customary closing conditions. TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab to Release First Quarter 2016 Financial Results on May 4, 2016 - Conference Call to Follow
GlobeNewswire - Mon Apr 25, 7:30AM CDT
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or the "Company"
will announce its first quarter 2016 financial results after market close on Wednesday, May 4, 2016. TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab Announces First Quarter 2016 Preliminary Financial Estimates
GlobeNewswire - Wed Apr 20, 4:20PM CDT
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or "the Company"
announced today certain preliminarily unaudited financial estimates for the first quarter of 2016. TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab to Participate in the 28th Annual ROTH Conference
GlobeNewswire - Thu Mar 10, 3:30PM CST
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or the "Company"
today announced its Chief Financial Officer, Wes Brazell, will present an update on the Company's business at the 28th Annual ROTH Conference on Monday, March 14, 2016 at 3:30 p.m. Pacific Time. The conference will be held at the Ritz Carlton in Dana Point, CA. TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab Reports Fourth Quarter and Full Year 2015 Financial Results
GlobeNewswire - Tue Mar 08, 3:03PM CST
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or the "Company"
today reported its consolidated financial results for the fourth quarter and full year ended December 31, 2015. All dollar amounts are expressed in U.S. currency and results are reported in accordance with United States generally accepted accounting principles. TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab Announces Withdrawal of Proposed Public Offering of Common Stock
GlobeNewswire - Tue Feb 09, 8:00PM CST
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or the "Company"
announced today that it has withdrawn the proposed underwritten public offering of its common stock, due to market conditions. TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab to launch USD15.0m common stock in underwritten public offering
M2 - Tue Feb 02, 6:09AM CST
Eye care technology company TearLab (Nasdaq CM:TEAR) disclosed on Monday that it proposes to issue USD15.0m shares of its common stock in an underwritten public offering.
TEAR: 0.59 (-0.01)
TearLab Announces Proposed Public Offering of Common Stock
GlobeNewswire - Mon Feb 01, 6:00AM CST
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or "the Company"
announced today its intention to offer, subject to market and other conditions, shares of its common stock in an underwritten public offering. The Company currently estimates the size of the offering at $15.0 million. In addition, TearLab intends to grant the underwriters of the offering the right for a period of 30 days to purchase up to an additional $2.25 million of shares of common stock at the public offering price, less underwriting discounts and commissions. The proceeds of the offering will be used for general corporate purposes, including commercializing our products, research and product development, capital expenditures, and working capital. TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab Announces Fourth Quarter 2015 Preliminary Financial Estimates and Provides Corporate Update
GlobeNewswire - Mon Feb 01, 6:00AM CST
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or "the Company"
announced today certain preliminarily unaudited financial estimates for the fourth quarter of 2015 and provided an update on its business. TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
BUYINS.NET: XPP, SIMO, SHM, ITM, AGZ, TEAR Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Dec 30, 6:15AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ProShares Ultra FTSE China 25 (NYSE:XPP), Silicon Motion Technology Corp (NASDAQ:SIMO), SPDR Nvn Barclys Cptl Shrt Trm Mncpl Bnd (NYSE:SHM), Intema Solutions Inc (NYSE:ITM), iShares Barclays Agency Bond Fund (NYSE:AGZ), Tearlab Corp (NASDAQ:TEAR) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
XPP: 44.04 (+1.75), TEAR: 0.59 (-0.01), ITM: 24.88 (+0.01), SHM: 49.05 (-0.01), AGZ: 115.79 (-0.25), SIMO: 52.20 (+1.81)
TearLab to Participate in November Investor Conferences
GlobeNewswire - Wed Nov 04, 8:00AM CST
TearLab Corporation (NASDAQ:TEAR); (TSX:TLB) ("TearLab" or the "Company"
announced today that it will participate in two investor conferences in November. TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab Corporation to Release Q3 2015 Financial Results on November 5, 2015
GlobeNewswire - Mon Oct 19, 3:53PM CDT
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or the "Company"
expects to announce its Q3 2015 financial results after market close on Thursday, November 5, 2015. TearLab is pleased to invite all willing participants in a conference call during which time financial results will be discussed. This call will be held at 4:30pm Eastern at 877-303-1593. TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
Medical Necessity of Tear Osmolarity Testing in the Diagnosis and Management of Dry Eye Disease Confirmed in Recently Published Medicare Local Coverage Determination
GlobeNewswire - Fri Oct 09, 6:00AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
announced today that First Coast Service Options, Inc. (the Medicare Area Contractor for Florida, Puerto Rico and the US Virgin Islands) has published a Local Coverage Determination (LCD) that confirms the role of tear osmolarity testing in the diagnosis and management of moderate to severe dry eye patients. TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab to Participate in Craig-Hallum's 6th Annual Alpha Select Conference
GlobeNewswire - Thu Sep 10, 7:00AM CDT
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or the "Company"
announced today that its Chief Executive Officer, Elias Vamvakas, will present an update on the Company's business at the 6th Annual Craig-Hallum Alpha Select Conference on Thursday, September 17, 2015 at 1:30 p.m. Eastern Time at the Convene Conference Center in New York City. TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
TearLab Corporation to Release Q2 2015 Financial Results on August 6, 2015
GlobeNewswire - Mon Jul 20, 8:30AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
expects to announce its Q2 2015 financial results after market closes on Thursday, August 6, 2015. TearLab is pleased to invite all willing participants in a conference call during which time financial results will be discussed. This call will be held at 4:30pm Eastern at 877-303-1593. TEAR: 0.59 (-0.01), TLB.TO: 0.81 (+0.01)
